Vis enkel innførsel

dc.contributor.authorVlasakova, Martina
dc.contributor.authorMuzik, Jan
dc.contributor.authorHolubova, Anna
dc.contributor.authorFiala, Dominik
dc.contributor.authorÅrsand, Eirik
dc.contributor.authorUrbanová, Jana
dc.contributor.authorŽďárská, Denisa Janíčková
dc.contributor.authorBrabec, Marek
dc.contributor.authorBrož, Jan
dc.date.accessioned2023-08-09T08:14:30Z
dc.date.available2023-08-09T08:14:30Z
dc.date.issued2023-04-28
dc.description.abstractBackground: Today’s diabetes-oriented telemedicine systems can gather and analyze many parameters like blood glucose levels, carbohydrate intake, insulin doses, and physical activity levels (steps). Information collected can be presented to patients in a variety of graphical outputs. Despite the availability of several technical means, a large percentage of patients do not reach the goals established in their diabetes treatment.<p> <p>Objective: The objective of the study was to evaluate the benefits of the Diani telemedicine system for the treatment of patients with type 1 diabetes mellitus. <p>Methods: Data were collected during a 24-week feasibility study. Patients responded to the World Health Organization Quality of Life – BREF (WHOQOL-BREF) questionnaire and a system evaluation questionnaire. The level of glycated hemoglobin (HbA<sub>1c</sub>) and the patient’s body weight were measured, and the patient’s use of the telemedicine system and their daily physical activity level were monitored. All data were sent from the patient’s device to the Diani server using a real-time diabetes diary app. Wilcoxon and Friedman tests and the linear mixed effects method were used for data analysis. <p>Results: This study involved 10 patients (men: n=5; women: n=5), with a mean age of 47.7 (SD 19.3) years, a mean duration of diabetes of 10.5 (SD 8.6) years, and a mean HbA<sub>1c</sub> value of 59.5 (SD 6.7) mmol/mol. The median number of days the patients used the system was 84. After the intervention, the mean HbA1c decreased by 4.35 mmol/mol (P=.01). The patients spent 18.6 (SD 6.8) minutes on average using the app daily. After the intervention, the number of patients who measured their blood glucose level at least 3 times a day increased by 30%. The graphical visualization of the monitored parameters, automatic transmission of measured data from the glucometer, compatibility, and interconnection of individual devices when entering data were positively evaluated by patients. <p>Conclusions: The Diani system was found to be beneficial for patients with type 1 diabetes mellitus in terms of managing their disease. Patients perceived it positively; it strengthened their knowledge of diabetes and their understanding of the influences of the measured values on the management of their disease. Its use had a positive effect on the HbA<sub>1c</sub> level.en_US
dc.identifier.citationVlasakova, Muzik, Holubova, Fiala, Årsand, Urbanová, Žďárská, Brabec, Brož. A Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Study. JMIR Formative Research. 2023;7en_US
dc.identifier.cristinIDFRIDAID 2159180
dc.identifier.doi10.2196/35064
dc.identifier.issn2561-326X
dc.identifier.urihttps://hdl.handle.net/10037/29791
dc.language.isoengen_US
dc.publisherJMIRen_US
dc.relation.journalJMIR Formative Research
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0en_US
dc.rightsAttribution 4.0 International (CC BY 4.0)en_US
dc.titleA Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Studyen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution 4.0 International (CC BY 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution 4.0 International (CC BY 4.0)